Application of Electronic Endoscope in Fetal Distress
Launched by THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIVERSITY · Sep 19, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method using an electronic endoscope to help diagnose and treat fetal distress during labor. Fetal distress can happen when a baby is not getting enough oxygen, which can be caused by issues like problems with the umbilical cord or abnormal amniotic fluid. Currently, doctors mostly rely on monitoring the baby’s heart rate to identify distress, but this method can sometimes give false alarms. The trial aims to see if using an endoscope can provide clearer images of what’s happening inside the uterus, allowing doctors to understand the causes of fetal distress better and potentially improve the situation for the baby, which may help reduce the need for cesarean sections.
To participate in the trial, women aged 20 to 45 who are experiencing fetal distress during labor may be eligible. This means that their water must have broken, and despite trying various treatments, the baby's heart rate is still concerning. Participants will be informed about the trial procedures and will need to give their written consent to join. Those with certain complications, such as severe infections or abnormal contractions, will not be eligible. Overall, this trial could lead to better outcomes for mothers and babies by improving how fetal distress is managed during childbirth.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects aged 20-45 years with single pregnancy;
- • 2. Intrauterine fetal distress occurs during labor (during the first stage of labor), and the fetal membrane was already broken;
- • 3. Fetal heart monitoring category II, after stopping oxytocin, oxygen inhalation, change of position, intravenous fluid and other measures can not improve;
- • 4. Understand the research procedures, be able to follow the procedures of the research protocol, and voluntarily sign a written consent.
- Exclusion Criteria:
- • 1. Type III fetal heart monitoring for pregnant women who require emergency c-section
- • 2. Pregnant women with GBS positive
- • 3. Pregnant women suspected of chorioamniotic infection
- • 4. Pregnant women have signs of reproductive system infection (vaginal inflammation, cervicitis, uterine infection)
- • 5. Pregnant women suspected of uterine rupture
- • 6. Pregnant women with abnormal contractions: excessive strong contractions
- • 7. Check the fetus for serious deformities during pregnancy
- • 8. Check pregnant women with serious abnormal functions of cardiovascular system, urinary system, digestive system, reproductive system and other organs
About The First Affiliated Hospital With Nanjing Medical University
The First Affiliated Hospital of Nanjing Medical University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital is committed to implementing rigorous scientific methodologies to evaluate new therapies and treatment approaches. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital fosters a collaborative environment aimed at enhancing patient outcomes and contributing to the global medical community. Its strategic focus on translational medicine ensures that groundbreaking discoveries are efficiently translated into practical applications for patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Jiangsu, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported